Highlights  Protocol for quantitative proteomics of nitrosylation on synaptosomal proteins.
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Introduction
Nitric oxide (NO) is a free radical that is biosynthesized by nitric oxide synthases.
NO contributes to numerous physiologic responses such as vasculature vasodilation, synaptic neurotransmission, respiration, inflammation, and apoptosis (Swomley et al., 2014) . One of the important biological modifications induced by NO is S-nitrosylation of cysteine (SNO), which functions in regulating signal transduction. In neurodegenerative disorders, aberrant SNO can propagate protein misfolding, mitochondrial dysfunction, synaptic injury, and neuronal death (Nakamura et al., 2013) . For example, increased levels of nitrosylated proteins have been reported in the brain of Alzheimer´s disease (AD) patients (Heneka et al., 2015) . As one of the earliest pathological characteristics of AD is synapse loss, our aim was to establish a robust protocol for the analysis of synaptosomal Snitrosylation in mouse and human brain samples. Synaptosomes consist of the presynaptic terminal (which contains synaptic vesicles and mitochondria), as well the postsynaptic density and postsynaptic membrane. They are preferably obtained by homogenization of brain tissue and density gradient centrifugation for enrichment of this specific compartment. (Swomley et al., 2014) .
Numerous proteomics techniques have been developed for detection and quantification of SNO (Qu et al., 2016) . However, many of these require high amounts of starting materials in the range of 100-500 µg of protein lysate (Wojdyla and Rogowska-Wrzesinska, 2015) . Furthermore, a common procedure applied to analyze SNO modification sites is induction of nitrosylation by use of NO-donors. It is difficult to compare the results from studies using NO donors to the in vivo situation, where cysteine S-nitrosylation depends on the undetermined concentrations of nitrosylating compounds (Zareba-Koziol et al., 2014) . Hence, identification of endogenous SNO levels derived from sub-fractionated compartments such as synaptosomes requires high sensitivity and specificity of the detection strategy.
Typical approaches for quantitative SNO proteomics are two-dimensional gel electrophoresis or liquid chromatography (LC) followed by mass spectrometry. Two-dimensional difference in-gel electrophoresis (2D-DIGE) has been described using a modified labeling procedure (NitroDIGE) (Qu et al., 2014b) . More frequently used is the biotin switch technique (BST) introduced by Jaffrey and Snyder 2001. It utilizes a replacement strategy to add a stable biotin into a SNO modification, allowing their detection and identification by antibodies or MS (Jaffrey and Snyder, 2001 ). More recently, an MS-based, isobaric tag labeling strategy was introduced in which peptides are linked with different tags and then fragmented to produce reporter ions of specific masses (Dayon and Sanchez, 2012) . Similar to BST, the commercially available labeling reagents (iodoTMT™ 126-131) are used for replacement chemistry of SNO modifications in a 6-plex multiplex (Qu et al., 2014a) . Although introduced in 2012, this approach has been barely described in the literature for samples with low amounts of starting material and under basal, endogenous conditions without NO donor treatment. This article provides detailed descriptions of the methodological workflow ( Figure 1 ) and efficiency of the iodoTMT™ protocol when applied to the analysis of synaptosomal samples, discussing both technical variances of the method as well as the comparability of findings with results previously published on this field. 
Materials and methods
Tissue samples
Three 9-months-old, male wild type mice were euthanized by isoflurance and transcardially perfused with ice-cold normal saline (0.9 % w/v NaCl). Mouse brain hemispheres without brainstem and cerebellum were prepared and immediately used for protein extraction. The method was transferred to two human frontal cortex brain samples from non-demented, non-diseased donors. Human brain samples were obtained from unfixed, frozen tissues with a postmortem interval of less than 4 h from the Banner Sun Health Research Institute Brain and Body Donation Program in Sun City, Arizona (Beach et al., 2008) . All subjects participating in the Banner Brain and Body Donation Program signed the written informed consent approved by the Banner Health Institutional Review Board.
Synaptosome isolation
For preparation of synaptosomes, 200 mg tissue where used with equal amounts of white and grey matter. Tissues were homogenized in 9-fold volume of tissue weight in 0.32 M sucrose buffer (50 mM Tris-acetate, 1 mM EDTA, 1 mM EGTA, 5 mM disodium pyrophosphate, 5 mM NaF, 2 mM Na3VO4, 1 mM AEBSF, cOmplete protease inhibitor cocktail (Sigma-Aldrich, Munich, Germany), pH 7.4). 
IodoTMT workflow for synaptosomal proteins
Protein labeling with iodoTMT
Three technical replicates were used to evaluate this approach. Synaptosome pellets were resuspended in 1 µg µL -1 HENS lysis buffer (Thermo Fisher Scientific).
Each synaptosome sample was prepared for six aliquots with an equal amount of proteins (50 µg), which were then individually labeled with iodoTMT sixplex labeling reagent followed by the optimized protocol. Subsequently, samples were digested, desalted, enriched, and analyzed by MS.
To avoid rearrangements of thiol-modifying groups, the protein mixture 
Tryptic digestion and peptide desalting
Alkylated samples were precipitated with acetone precipitation and dissolved in 50 mM ammonium bicarbonate buffer, pH 8 for overnight digestion using trypsin (protein : trypsin ratio = 1:40 w/w) at 37 °C. The peptides were acidified with 10% trifluoroacetic acid to final concentration of 0.5%, purified using C18 spin columns (Thermo Fisher Scientific) and eluted with 70% (v/v) acetonitrile (ACN).
Enrichment of iodoTMT-labeled peptides
For the enrichment step, the labeled peptides were dried by vacuum centrifugation and resuspended in 100 μL TBS buffer (150 M NaCl, 50 mM Tris, pH 8.0). The peptide samples were incubated with 30 μL anti-TMT resin for 2.5 h at room temperature with end-over-end mixing. The resin was washed three times with 100 μL TBS followed by three washing steps with 100 μL HPLC-grade water. Peptides were eluted twice with 30 μL TMT elution buffer (Thermo Fisher Scientific). 
Data analysis and protein identification
For data processing and analyses of database searches, Proteome Discoverer software 2.1.0.81 (Thermo Fisher Scientific) was used. Peptide identification was done on an in-house Mascot server, version 2.5.1 (Matrix Science Ltd, London, UK). MS2 data (including a-series ions) were matched against mouse / human sequences from SwissProt (release 2015_04). Precursor Ion m/z tolerance was Up to two missed cleavages were allowed for tryptic peptides. Low scoring spectrum matches were re-analyzed with semitryptic specificity with up to one missed cleavage. Carbamidomethylation (Cys), Oxidation (Met), acetylation (protein N-terminus), and iodoTMT sixplex (on Cys) were set as dynamic modifications. Mascot results from searches against SwissProt were sent to the percolator algorithm version 2.05 as implemented in Proteome Discoverer.
Peptides were identified with a posterior error probability of 1% or better. Proteins were reported with at least one matching peptide because of the experimental design: In cases where only one site in a protein is nitrosylated, only one labeled peptide can be identified after enrichment.
Results and discussions
Method performance
Technical characterization of the method was tested first on wild-type mouse samples (n = 3) and then transferred to human brain samples (n = 2) from donors without CSN disorders. To test reporter ion intensity and determine inter-sample variances, aliquots of the same samples were labeled with IodoTMT™ sixplex reagents, one for each aliquot, and then pooled and analyzed (same-sameexperiment). A representative MS/MS spectrum with intense reporter ions and a clear b-and y-series of assigned fragment ions is shown in figure 1B . When comparing reporter ion intensities from the same-same-experiment over all identified peptides between all of the 6 labels, there was an average variance of 20% between single reporter ion channels and the mean of all channels, quantified over all of the identified peptides. This indicates that the overall technical variance of the method, including preparative pipetting, sample handling, digestion, IodoTMT™ labeling and enrichment until pooling and analysis of the samples, was within this range.
In theory, all identified peptides should contain a TMT™ label attached to a previously nitrosylated cysteine. Within our dataset, an average of 72% of identified peptides contained cysteine, among which 93%-98% were labeled with IodoTMT™. In conclusion, cysteine-targeted labeling was highly specific, whereas the anti-TMT-antibody based enrichment and purification strategy could not completely remove non-modified peptides. There was barely any unspecific TMTlabeling (<1% of peptides) on the peptide N-terminus (which is the target of the regular TMT™ protocol). Noteworthy, it was not possible to identify nitrosylated peptides form the synaptosome samples without application of the labeling/enrichment strategy.
Proteome analysis
In murine synaptosomes 1462 unique peptides were identified representing 617 proteins, of which 42% were identified for the first time. In human synaptosomes, 570 unique peptides were identified representing 337 proteins, of which 73% were identified for the first time (by comparing to the SNO database http://dbSNO.mbc.nctu.edu.tw). In comparison, the absolute number of SNOmodified proteins was 2.6-fold higher in mouse proteins compared to human (Venturini et al., 1999) . For human samples, the post mortem interval was limited to a maximum of 4 h for this study, but this time window might already impact the yield of nitrosylated proteins. Additionally, synaptosomes from mouse brains could be prepared without freeze-thaw cycles, while human brain samples were obtained as frozen material from a biobank, which did not prepare its specimen specifically for this type of analysis. Supposable, the SNO proteome could be further preserved by use of appropriate chemical stabilizers or inhibitors additional to cooling and protease inhibitors, as it is common practice in example for phosphoproteomics. To our knowledge, such substances have not found
widespread use yet, although some studies reported use of inhibitors (Koo et al. 2016 & Foster et al. 2012 . Lastly, there might be substantial species-derived differences between murine and human samples, which cannot be entirely distinguished from method-derived differences to this point.
The composition of the SNO-proteome was analyzed using Gene Ontology enRIchment anaLysis and visuaLiAtion (Gorilla) search engine (Eden et al., 2007) and Uniprot/SwissProt based on the localization classification (UniProt, 2015). The
Gorilla search engine result (illustrated in figure 2A majority of cytoplasm 24-28%, mitochondria 24-34%, cell membrane 14-22%, and synapse 6-11%. We also found nuclear and endoplasmic reticulum associated proteins resulting from small fragments of these organelles with similar density as synaptosomes.
For the murine samples, these numbers are comparable with, if not higher than, those described in previous reports on synaptosome samples: In example, SNOSID (SNO side identification) analysis using BST identified 138 SNO proteins (Zareba-Koziol et al., 2014) of which 85% were found to overlap with our results (see figure 2G) ; and TMT (Tandem Mass Tag) labeling analysis identified 240 proteins (figure 2F), both from murine synaptosome. For human samples, to our knowledge, there are no published data for synaptosome-derived SNOproteomes. We found that the overall composition of the detected proteome is congruent with previous publications on the synaptosome proteome labeled with TMT independent of their modifications ( figure 2D ) (Engmann et al., 2010) and with BST on SNOSID ( figure 2E ) (Zareba-Koziol et al., 2014) . 
Advantages and limitations
The iodoTMT approach showed a large number of identified proteins obtained from a small amount of starting material (50 µg of protein from synaptosome lysate).
The number of identified SNO proteins was comparable or higher in comparison to previous studies. Further advantages include high labeling specificity and the use of one stable labeling for enrichment, identification and multiplex quantitation of modified proteins. Also, this protocol was functional for identification of endogenous levels of SNO proteins, without prior induction of nitrosylation by NO donor treatment. Finally, the iodoTMT protocol was easy to adapt and did not require extensive method optimization.
However, this approach also has limitations. The stability of the iodoTMT labeling reagent after reconstitution is limited to 1 week when stored at -20 °C. Therefore, it is recommendable to perform all labeling steps for a study within this time frame.
Another limitation stems from the nature of the labeling and enrichment procedure:
As only modified peptides are identified and quantified, the procedure frequently depends on MS/MS-based information implied from a single peptide ion. This limits the number of peptides available for protein identification, which in consequence should be achieved from that single peptide. Therefore, protein identifications are only valid when derived from unique (protein-specific) modified peptides. If identified peptides are not unique, multiple proteins or protein classes have to be considered as potential origin of the peptide.
Although highly efficient, the entire workflow consists of multiple steps (such as blocking, labeling, enrichment, cleaning, digestion) which are time-consuming and can add up to inter-run variances, which were in an average range of 20% in the same-same experiments. To control this in quantitative studies, we suggest setting up an internal standard that contains pooled and aliquoted proteins of all representative samples. This standard should be added at the beginning of each preparation batch and be analyzed as one of the sixplex samples on each LC-MCrun, hence enabling to control for any technical failures or irregularities that interfere with quantitation. Although this standard cannot reduce inter-runvariances, it could be used to characterize and monitor such variances for quality control purposes.
Conclusions
In summary, the protocol possesses many advantages in terms of enrichment, specificity, and quantitation, all based on a single labeling reaction. Additionally, the IodoTMT approach enables sample (6-plex) multiplexing. The protocol was sensitive enough to utilize low amounts of starting material while at the same time providing data comparable to previously published results. Given the increasing scientific interest on protein S-nitrosylation (Qu et al., 2016) , we anticipate it to be useful for other researchers analyzing this instable protein modification, especially when dealing with limited amounts of samples such as in analysis of synaptosomes or other cellular compartments.
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